Long-term survival after detecting tumor cells in head and neck cancer
Author Information
Author(s): Stuart C Winter, Sally-Anne Stephenson, Selva K Subramaniam, Vinidh Paleri, Kien Ha, Conor Marnane, Suren Krishnan, Guy Rees
Primary Institution: Royal Adelaide Hospital
Hypothesis
Can detecting circulating tumor cells in patients with head and neck squamous cell carcinoma predict long-term survival outcomes?
Conclusion
Most patients with advanced head and neck cancers have circulating tumor cells at the time of surgery, indicating a need for further exploration of detection techniques.
Supporting Evidence
- The study detected circulating tumor cells in 87.5% of patients with advanced disease.
- Detection of circulating tumor cells was not associated with significant differences in overall or disease-free survival.
- The immunobead RT-PCR method was optimized for detecting circulating tumor cells in blood samples.
Takeaway
Doctors found that many patients with serious throat and neck cancers have tiny cancer cells in their blood during surgery, which could help in understanding how to treat them better.
Methodology
The study used immunobead RT-PCR to detect circulating tumor cells in blood samples from patients before and after surgery.
Potential Biases
Potential bias due to the small sample size and the specific patient population studied.
Limitations
The study had a small sample size and all patients had advanced disease, which may limit the generalizability of the findings.
Participant Demographics
16 patients (14 males and 2 females) with advanced head and neck squamous cell carcinomas, median age 59 years.
Statistical Information
P-Value
0.02
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website